一种系统生物学方法,在人类主要癌症中揭示共同的治疗目标和病理途径
Aftab Alam1, Mohd Faizan Siddiqui2, Rifat Hamoudi3,4,5
1Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
研究人员确定了26个关键基因在多种癌症类型中共享,提供了新的诊断和预后标志物. 这些交叉癌症基因揭示了共同的分子机制,有助于开发针对性治疗乳腺癌,肺癌,结肠直肠癌和前列腺癌.
科学领域:
- 基因组学就是基因组学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 癌症表现出不同的临床和分子特征,但基本的共享机制尚未得到充分探索.
- 识别不同癌症类型的共同分子通路对于推进诊断和治疗至关重要.
研究的目的:
- 在四种流行癌症类型 (乳腺,肺,结直肠,前列腺) 中发现具有诊断和预后价值的共享分子签名.
- 识别可靠的基因特征,反映出常见的致癌机制和临床特征.
主要方法:
- 癌症基因组图谱 (TCGA) 数据集的系统转录形状.
- 综合性分析包括差异表达,弹性网,权重基因同表达网络分析 (WGCNA),蛋白与蛋白相互作用 (PPI) 和马尔科夫集群算法 (MCL) 集群.
- 全癌症评估和生存分析,以评估诊断和预后潜力.
主要成果:
- 确定了179个跨癌症特征基因,改进为26个强大的枢纽基因,具有显著的诊断潜力.
- 通过生存分析证明了这些枢纽基因的强烈预后价值.
- 在20多种癌症类型中观察到枢纽基因的一致失调,具有上下文依赖的免疫调节作用.
- 突出了与转移相关的16个枢纽基因,表现出瘤抑制和瘤致癌功能.
- 开发了一个基于枢纽基因的签名,具有作为预后标记物的潜力.
结论:
- 在不同类型的癌症中存在共享的分子机制,为泛癌症治疗策略提供了机会.
- 已识别的枢纽基因作为有价值的诊断和预后生物标志物.
- 这项研究提供了对常见的瘤性途径的见解,支持开发向疗法和改进癌症管理.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer
